Literature DB >> 29052824

Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier's gangrene: A multicenter study.

Orhan Üreyen1, Atahan Acar, Uğur Gökçelli, Murat Kemal Atahan, Enver İlhan.   

Abstract

BACKGROUND: This study aimed to evaluate the usefulness of Fournier's gangrene scoring index (FGSI) and Uludag FGSI (UFGSI) for predicting mortality in patients with FG.
METHODS: Patients who underwent treatment and follow-up in the A division department of general surgery at two education and research hospitals between January 2012 and December 2015 were evaluated for mortality-related factors. The sensitivities of FGSI and UFGSI scoring systems for predicting mortality-related factors and disease prognosis were evaluated. Patients were grouped as survivors (Group I) or non-survivors (Group II).
RESULTS: In total, 29 patients were included in the study. The mean age (±SD) was 51.52±13.36 years. The mortality rate was 20.6% (six patients). Bacterial growth was observed in wound cultures of 17 patients (58.6%). Of the patients with bacterial growth, 11 (47.8%) were in Group I and six (100%) were in Group II. The presence of bacterial growth was significantly associated with mortality (p=0.028). Fourteen patients (48.3%) had comorbid conditions. The number of comorbid conditions was related (p=0.049). FGSI and UFGSI scores were significantly higher in Group II than in Group I (p=0.002 and p=0.001, respectively). Among UFGSI parameters, extent of disease, body temperature, pulse rate, and HCO3 values were significantly higher in Group II than in Group I (p<0.05). The FGSI and UFGSI scoring systems had 100% sensitivity and 78.2% and 73.9% specificity, respectively, for predicting mortality.
CONCLUSION: The FGSI and UFGSI scoring systems are valuable for predicting mortality in patients with FG. The extent of the disease was an important prognostic parameter in this study. Whichever scoring system is used, we suggest the use of the extent of disease score in UFGSI.

Entities:  

Mesh:

Year:  2017        PMID: 29052824     DOI: 10.5505/tjtes.2017.71509

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  6 in total

1.  A different perspective for morbidity related to Fournier's gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier's gangrene?

Authors:  Ismail Selvi; Aykut Aykac; Ozer Baran; Salih Burlukkara; Ugur Ozok; Mehmet Melih Sunay
Journal:  Int Urol Nephrol       Date:  2019-06-08       Impact factor: 2.370

2.  Global outcomes and lessons learned in the management of Fournier's gangrene from high-volume centres: findings from a literature review over the last two decades.

Authors:  Daniel Bowen; Patrick Juliebø-Jones; B K Somani
Journal:  World J Urol       Date:  2022-09-04       Impact factor: 3.661

3.  Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting.

Authors:  Ngwobia Peter Agwu; Abubakar Sadiq Muhammad; Abdulwahab-Ahmed Abdullahi; Bello Bashir; Jacob Ndas Legbo; Ismaila Arzika Mungadi
Journal:  Urol Ann       Date:  2020-07-17

4.  A rare case of retroperitoneal extension in Fournier's gangrene: A case report and review of literature.

Authors:  Sunil Basukala; Yugant Khand; Soumya Pahari; Kunda Bikram Shah; Aashish Shah
Journal:  Ann Med Surg (Lond)       Date:  2022-04-09

5.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19

6.  Validation of FGSI Scores in Predicting Fournier Gangrene in Tertiary Hospital.

Authors:  Bambang Sasongko Noegroho; Safendra Siregar; Akhmad Mustafa; Muhammad Aldito Rivaldi
Journal:  Res Rep Urol       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.